JPS5936611B2 - ペプチドの製造方法 - Google Patents

ペプチドの製造方法

Info

Publication number
JPS5936611B2
JPS5936611B2 JP48079221A JP7922173A JPS5936611B2 JP S5936611 B2 JPS5936611 B2 JP S5936611B2 JP 48079221 A JP48079221 A JP 48079221A JP 7922173 A JP7922173 A JP 7922173A JP S5936611 B2 JPS5936611 B2 JP S5936611B2
Authority
JP
Japan
Prior art keywords
phe
group
glu
peptide
boc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP48079221A
Other languages
English (en)
Japanese (ja)
Other versions
JPS4951278A (enExample
Inventor
マリ−ノグレベン ヘンドリク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of JPS4951278A publication Critical patent/JPS4951278A/ja
Publication of JPS5936611B2 publication Critical patent/JPS5936611B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP48079221A 1972-07-15 1973-07-13 ペプチドの製造方法 Expired JPS5936611B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL7209839 1972-07-15
NLAANVRAGE7209839,A NL175618C (nl) 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.

Publications (2)

Publication Number Publication Date
JPS4951278A JPS4951278A (enExample) 1974-05-18
JPS5936611B2 true JPS5936611B2 (ja) 1984-09-05

Family

ID=19816526

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48079221A Expired JPS5936611B2 (ja) 1972-07-15 1973-07-13 ペプチドの製造方法

Country Status (13)

Country Link
US (1) US3853838A (enExample)
JP (1) JPS5936611B2 (enExample)
AU (1) AU471401B2 (enExample)
BE (1) BE802335A (enExample)
CA (1) CA1019723A (enExample)
CH (1) CH605674A5 (enExample)
DE (1) DE2335826C2 (enExample)
FR (1) FR2192838B1 (enExample)
GB (1) GB1439225A (enExample)
HU (1) HU169437B (enExample)
NL (1) NL175618C (enExample)
SE (1) SE392721B (enExample)
ZA (1) ZA734648B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607683A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4144228A (en) * 1976-05-07 1979-03-13 G. D. Searle & Co. Methionine5 -enkephalin sulfoxides and sulfones
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
RU2315057C2 (ru) * 2006-02-17 2008-01-20 Закрытое акционерное общество "Синтез пептидов" Способ получения аналогов аденокортикотропного гормона (актг), последовательности (4-10), обладающих нейротропной активностью, и тетрапептид для его получения
US20130059914A1 (en) 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
KR20230174213A (ko) 2021-03-09 2023-12-27 엔사이스 바이오사이언시즈 인크. 나파모스타트의 변형된 방출 조성물 및 그의 사용 방법
CN117715632A (zh) 2021-03-09 2024-03-15 恩赛斯生物科学股份有限公司 包含酶可裂解的前药和萘莫司他的组合物及其使用方法
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278010A (enExample) * 1961-05-04 1900-01-01
NL6509727A (enExample) * 1965-07-28 1967-01-30
GB1230472A (enExample) * 1967-07-10 1971-05-05

Also Published As

Publication number Publication date
NL175618B (nl) 1984-07-02
FR2192838B1 (enExample) 1977-01-28
HU169437B (enExample) 1976-11-28
CA1019723A (en) 1977-10-25
NL7209839A (enExample) 1974-01-17
US3853838A (en) 1974-12-10
CH605674A5 (enExample) 1978-10-13
DE2335826A1 (de) 1974-01-31
DE2335826C2 (de) 1984-01-05
JPS4951278A (enExample) 1974-05-18
FR2192838A1 (enExample) 1974-02-15
ZA734648B (en) 1974-06-26
SE392721B (sv) 1977-04-18
AU471401B2 (en) 1976-04-29
BE802335A (fr) 1974-01-14
AU5798373A (en) 1975-01-16
NL175618C (nl) 1984-12-03
GB1439225A (en) 1976-06-16

Similar Documents

Publication Publication Date Title
FI73699B (fi) Foerfarande foer framstaellning av nya, som laekemedel anvaendbara peptider.
US3853836A (en) Psychopharmacologically active peptides related to acth
US6235876B1 (en) Liquid phase process for the preparation of GNRH peptides
US3842064A (en) Psychopharmacologically active tetra-,penta-,hexa-,and hepta-peptides
KR960010349B1 (ko) 2, 3-이치환된 이속사졸리딘, 그의 제조방법, 그를 함유하는 제제 및 그의 용도
SE447389B (sv) Nya tripeptider, som inverkar pa det centrala nervsystemet
Bodanszky et al. o-Nitrophenyl esters of benzyloxycarbonylamino acids and their application in the synthesis of peptide chains by the in situ technique
JPS63284197A (ja) ホスホリパーゼａ↓２‐阻止作用を有するペプチド
US3853838A (en) Sedative peptides related to acth containing a d-phe moiety
US4439359A (en) Cyclic octapeptide analogs of neurotensin
US5811389A (en) Tri- and tetracyclic compounds
US3856770A (en) Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
US3850904A (en) Psychopharmacologically active d-glu or d-his containing peptides
US3862927A (en) Process for preparation of vasoactive intestinal peptide
US4260601A (en) Chemical compounds
HU180925B (en) Process for producing tripeptide-amides trh-analogues,effectives on the central nerve systhem
CA1105926A (en) L-pyroglutamyl-l-histidyl-glycine
KR100825537B1 (ko) 페린도프릴 및 이의 약학적으로 허용되는 염의 합성 방법
Brand et al. Optical Rotation of Peptides. V. Alanine Tetra-, Penta-and Hexapeptides1
JPS61155395A (ja) ｒｅｔｒｏ逆転ペプチド及びその合成法
US3247178A (en) Synthesis of peptides containing alpha, omega-diamino acids protected by phthalyl and t-butyloxycarbonyl groups
CA1131217A (en) Psycho-pharmacological peptides
US4247543A (en) Organic compounds
GB2127831A (en) Intermediates in the preparation of caerulein
EP1440977B1 (fr) Procédé de synthèse amélioré de dérivés diamides du tripeptide KPV